Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E

Louis Pelus, S. Saletan, R. T. Silver, M. A S Moore

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The presence of Ia-antigens and their relationship to the inhibitory effect of prostaglandin E on the proliferation of human CFU-GM was studied in normals and patients with chronic myeloid leukemia. Consistent reduction of normal colony formation to approximately 50% of baseline levels was observed using a monoclonal anti-human Ia antibody in a complement-dependent cytotoxicity assay titrated over serial dilutions. Elimination of the Ia-antigen-bearing CFU-GM population was associated with virtually a complete loss of responsiveness to the inhibitory effects of prostaglandin E. Maintenance of bone marrow cells in short-term suspension culture at 37°C prior to agar culture resulted in the loss of detectable Ia-antigen on the CFU-GM and, similarly, loss of response to prostaglandin. In contrast, most patients with chronic myeloid leukemia showed greatly reduced levels of Ia-antigens on their CFU-GM in fresh marrow together with lack of prostaglandin sensitivity, suggesting a correlation with the abnormal growth regulation observed in these patients. In two chronic myeloid leukemia patients, levels of Ia-antigen higher than that observed in the majority of patients could be detected and correlated with a residual response to prostaglandin E. These results suggst a relationship in normals between the expression of Ia-antigens on CFU-GM and the physiologic response to regulation by prostaglandin E, and a possible mechanism for the aberrant regulatory response in patients with chronic myeloid leukemia.

Original languageEnglish (US)
Pages (from-to)284-292
Number of pages9
JournalBlood
Volume59
Issue number2
StatePublished - 1982
Externally publishedYes

Fingerprint

Granulocyte-Macrophage Progenitor Cells
Macrophages
Histocompatibility Antigens Class II
Cell proliferation
Prostaglandins E
Granulocytes
Cell Proliferation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Prostaglandins
Bearings (structural)
Cytotoxicity
Cell culture
Bone Marrow Cells
Dilution
Agar
Assays
Suspensions
Bone
Bone Marrow
Cells

ASJC Scopus subject areas

  • Hematology

Cite this

Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E. / Pelus, Louis; Saletan, S.; Silver, R. T.; Moore, M. A S.

In: Blood, Vol. 59, No. 2, 1982, p. 284-292.

Research output: Contribution to journalArticle

@article{3693e4a3b9f941158db24a2a1ace064a,
title = "Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E",
abstract = "The presence of Ia-antigens and their relationship to the inhibitory effect of prostaglandin E on the proliferation of human CFU-GM was studied in normals and patients with chronic myeloid leukemia. Consistent reduction of normal colony formation to approximately 50{\%} of baseline levels was observed using a monoclonal anti-human Ia antibody in a complement-dependent cytotoxicity assay titrated over serial dilutions. Elimination of the Ia-antigen-bearing CFU-GM population was associated with virtually a complete loss of responsiveness to the inhibitory effects of prostaglandin E. Maintenance of bone marrow cells in short-term suspension culture at 37°C prior to agar culture resulted in the loss of detectable Ia-antigen on the CFU-GM and, similarly, loss of response to prostaglandin. In contrast, most patients with chronic myeloid leukemia showed greatly reduced levels of Ia-antigens on their CFU-GM in fresh marrow together with lack of prostaglandin sensitivity, suggesting a correlation with the abnormal growth regulation observed in these patients. In two chronic myeloid leukemia patients, levels of Ia-antigen higher than that observed in the majority of patients could be detected and correlated with a residual response to prostaglandin E. These results suggst a relationship in normals between the expression of Ia-antigens on CFU-GM and the physiologic response to regulation by prostaglandin E, and a possible mechanism for the aberrant regulatory response in patients with chronic myeloid leukemia.",
author = "Louis Pelus and S. Saletan and Silver, {R. T.} and Moore, {M. A S}",
year = "1982",
language = "English (US)",
volume = "59",
pages = "284--292",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E

AU - Pelus, Louis

AU - Saletan, S.

AU - Silver, R. T.

AU - Moore, M. A S

PY - 1982

Y1 - 1982

N2 - The presence of Ia-antigens and their relationship to the inhibitory effect of prostaglandin E on the proliferation of human CFU-GM was studied in normals and patients with chronic myeloid leukemia. Consistent reduction of normal colony formation to approximately 50% of baseline levels was observed using a monoclonal anti-human Ia antibody in a complement-dependent cytotoxicity assay titrated over serial dilutions. Elimination of the Ia-antigen-bearing CFU-GM population was associated with virtually a complete loss of responsiveness to the inhibitory effects of prostaglandin E. Maintenance of bone marrow cells in short-term suspension culture at 37°C prior to agar culture resulted in the loss of detectable Ia-antigen on the CFU-GM and, similarly, loss of response to prostaglandin. In contrast, most patients with chronic myeloid leukemia showed greatly reduced levels of Ia-antigens on their CFU-GM in fresh marrow together with lack of prostaglandin sensitivity, suggesting a correlation with the abnormal growth regulation observed in these patients. In two chronic myeloid leukemia patients, levels of Ia-antigen higher than that observed in the majority of patients could be detected and correlated with a residual response to prostaglandin E. These results suggst a relationship in normals between the expression of Ia-antigens on CFU-GM and the physiologic response to regulation by prostaglandin E, and a possible mechanism for the aberrant regulatory response in patients with chronic myeloid leukemia.

AB - The presence of Ia-antigens and their relationship to the inhibitory effect of prostaglandin E on the proliferation of human CFU-GM was studied in normals and patients with chronic myeloid leukemia. Consistent reduction of normal colony formation to approximately 50% of baseline levels was observed using a monoclonal anti-human Ia antibody in a complement-dependent cytotoxicity assay titrated over serial dilutions. Elimination of the Ia-antigen-bearing CFU-GM population was associated with virtually a complete loss of responsiveness to the inhibitory effects of prostaglandin E. Maintenance of bone marrow cells in short-term suspension culture at 37°C prior to agar culture resulted in the loss of detectable Ia-antigen on the CFU-GM and, similarly, loss of response to prostaglandin. In contrast, most patients with chronic myeloid leukemia showed greatly reduced levels of Ia-antigens on their CFU-GM in fresh marrow together with lack of prostaglandin sensitivity, suggesting a correlation with the abnormal growth regulation observed in these patients. In two chronic myeloid leukemia patients, levels of Ia-antigen higher than that observed in the majority of patients could be detected and correlated with a residual response to prostaglandin E. These results suggst a relationship in normals between the expression of Ia-antigens on CFU-GM and the physiologic response to regulation by prostaglandin E, and a possible mechanism for the aberrant regulatory response in patients with chronic myeloid leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0020053597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020053597&partnerID=8YFLogxK

M3 - Article

C2 - 6173083

AN - SCOPUS:0020053597

VL - 59

SP - 284

EP - 292

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -